NCT02186015View on ClinicalTrials.gov

Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D)

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

March 8, 2017

Study Completion Date

November 9, 2017

Conditions
Adult WomenMetastatic Breast CancerEstrogen Receptor Positive
Interventions
DRUG

Cholecalciferol

Enrolled women will receive 50,000 IU weekly supplementation of cholecalciferol for 8 weeks.

Trial Locations (1)

60153

Loyola University Medical Center, Maywood

All Listed Sponsors
lead

Loyola University

OTHER

NCT02186015 - Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D) | Biotech Hunter | Biotech Hunter